Stock Markets May 11, 2026 08:20 AM

Cerebras Expands IPO Size and Price Range to Tap Strong Investor Demand

Sunnyvale AI chipmaker hikes offering to roughly $4.8 billion after receiving heavy orders for Nasdaq debut

By Marcus Reed

Cerebras Systems has increased both the number of shares and the price range for its planned Nasdaq initial public offering, reflecting robust investor interest. The Sunnyvale, California-based maker of AI processors is now offering 30,000,000 shares at $150 to $160 each, potentially raising about $4.8 billion. The company earlier proposed 28,000,000 shares at $115 to $125. Orders have reportedly exceeded available shares by a factor greater than 20, and the offering is scheduled to be priced on May 13.

Cerebras Expands IPO Size and Price Range to Tap Strong Investor Demand

Key Points

  • Cerebras raised the IPO size to 30,000,000 shares with a $150-$160 price range, potentially bringing in about $4.8 billion; the initial proposal was 28,000,000 shares at $115-$125.
  • The offering has reportedly attracted orders exceeding supply by more than 20 times, and the company plans to price the IPO on May 13.
  • Sectors impacted include semiconductors, AI infrastructure, and capital markets given the scale of the offering and the firm's positioning in inference-focused processors.

Cerebras Systems said on Monday that it has boosted the scope and price band for its initial public offering as investor demand for the artificial intelligence-focused chipmaker strengthened.

The Sunnyvale, California-based company revised its filing to offer 30,000,000 shares of common stock with a proposed price range of $150 to $160 per share. Under its earlier terms, Cerebras had indicated an offering of 28,000,000 shares priced between $115 and $125. At the top end of the new range, the company would generate roughly $4.8 billion from the sale, compared with about $3.5 billion under the initial proposal.

Sources reported that orders for the IPO exceed the number of shares available by more than 20 times, a level of demand that supported the upsized offer. Cerebras intends to set the final price for the offering on May 13.

Underwriting group and additional banks

Morgan Stanley, Citigroup, Barclays and UBS Investment Bank are serving as the lead underwriters on the deal. Additional underwriters named in the filing include Mizuho, TD Cowen, Needham & Company, Craig-Hallum, Wedbush Securities, Rosenblatt, Academy Securities, Credit Agricole CIB, MUFG and First Citizens Capital Securities.

Product positioning and customer list

Cerebras develops specialized processors aimed at running advanced AI models. The company sells chips designed to support inference workloads - the computations that enable models to answer user queries - in a market that the filing describes as dominated by Nvidia. According to the company, demand for its processors has grown as AI development shifts from the training phase toward deployment and inference.

The filing also notes that Cerebras has secured several major AI infrastructure customers, explicitly naming Amazon and OpenAI among its clients.

With the offering planned for Nasdaq and pricing set for May 13, the company and its underwriting syndicate will complete final allocations and pricing based on ongoing investor interest.

Risks

  • Final pricing and allocation depend on investor demand and will be set on May 13 - outcomes could change up to that pricing date, affecting capital raised.
  • Cerebras operates in a market described as dominated by Nvidia, highlighting competitive pressure in the semiconductor and AI infrastructure sectors.
  • The company lists major customers such as Amazon and OpenAI; reliance on a small set of large infrastructure clients could concentrate revenue exposure.

More from Stock Markets

S&P Moves Mexico’s Outlook to Negative, Citing Fiscal Strain and Tepid Growth May 12, 2026 Moody's Lowers Everforth Outlook to Negative Amid Elevated Leverage May 12, 2026 Moody's Moves Albemarle Outlook to Stable After Debt Cuts and Stronger Lithium Prices May 12, 2026 Moody's Keeps Garrett Motion Rating Steady, Moves Outlook to Positive May 12, 2026 S&P Lowers Embecta Rating After Sharp Revenue Drop and Market Share Loss May 12, 2026